Last reviewed · How we verify

NCT03362450

Prenatal Diagnosis of Antenatal Midgut Volvulus: Specific Ultrasound Features

Completed Last updated 5 December 2017
What this trial tests

trial testing Fetal ultrasound during the second or third trimester/ Postnatal surgery / Post mortem examination in Fetal Volvulus in 13 participants. Completed in 30 September 2017.

Timeline
1 January 2006
Primary endpoint
1 July 2017
30 September 2017

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment13
Start date1 January 2006
Primary completion1 July 2017
Estimated completion30 September 2017
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, female only, with Fetal Volvulus or Midgut Volvulus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: The small bowel volvulus is a rare cause of intestinal obstruction which may occur in utero and whose prenatal diagnosis is difficult.Sonographic signs are mainly indirect and non specific.The aim of this study is to present a retrospective analysis of prenatal sonographicfindings in fetal segmental midgut volvulus.Thanks to this series the investigators could highlight the more specifics signs of the volvulus included a new pattern.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03362450.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing